Molecular dynamics (MD) has become a routine tool in structural biology and structure-based drug design (SBDD). MD offers extraordinary insights into the structures and dynamics of biological systems. With the current capabilities of high-performance supercomputers, it is now possible to perform MD simulations of systems as large as millions of atoms and for several nanoseconds timescale. Nevertheless, many complicated molecular mechanisms, including ligand binding/unbinding and protein folding, usually take place on timescales of several microseconds to milliseconds, which are beyond the practical limits of standard MD simulations. Such issues with traditional MD approaches can be effectively tackled with new generation MD methods, such as enhanced sampling MD approaches and coarse-grained MD (CG-MD) scheme. The former employ a bias to steer the simulations and reveal biological events that are usually very slow, while the latter groups atoms as interaction beads, thereby reducing the system size and facilitating longer MD simulations that can witness large conformational changes in biological systems. In this review, we outline many of such advanced MD methods, and discuss how their applications are providing significant insights into important biological processes, particularly those relevant to drug design and discovery.FIGURE 1 | A schematic representation of a metadynamics protocol. The figure shows that a mock system (in yellow color) is initially trapped in a local minimum. During metadynamics, the Gaussian potentials (Gaussians shown in blue) are added to the energy wells, such that the system reaches the first saddle point only to fall into the next energy well. This process is iterated until all possible energetic wells are filled with Gaussians, thus leading to a flat energy surface.
Overview